The present study was performed to investigate the effect of 0-endorphin on macrophage colony-stimulating factor (M-CSF)-induced differentiation of macrophages from bone marrow cells in a semisolid culture system. 0-endorphin increased the number of macrophage colonies when bone marrow cells were cultured in the presence of M-CSF plus lipopolysaccharide (LPS). This was not the case with LPSunresponsive C3HIHeJ mouse bone marrow cells. a-endorphin and y-endorphin were as effective as &endorphin in enhancing the colony formation. Exogenous interleukin-l (IL-l), but neither IL-6 nor tumor necrosis factor (TNF), collaborated with &endorphin even in the absence of LPS. suggesting that IL-l is a primary mediator of the effect of LPS.
are involved in the immune system.*-' In addition, it has been reported that various activities of the leukocytes are influenced by the binding of endorphins to their opioid receptors on cell Therefore, it is likely that endorphins are a regulator for the immune system.
We previously reported that several structurally related opioid peptides, including P-endorphin, potentiate the tumoricidal activity of weakly activated macrophages via classical opioid receptors.'' The acquisition of tumoricidal activity is the end result of a stepwise differentiation and activation of macrophages. Developmental differentiation of macrophages takes place mainly in the bone marrow, and macrophage colony-stimulating factor (M-CSF) is known to play a key role in this process. Other factors such as interleukin (1L)-l, tumor necrosis factor a (TNFa), IL-3, and IL-6 have been reported to collaborate with M-CSF.'7-2' Moore et alZ4 documented that M-CSF-induced differentiation of murine bone marrow cells to macrophages was facilitated by the addition of lipopolysaccharide (LPS) in the in vitro colony assay.24 They also documented that substance P, one of the neuropeptides, further enhanced the M-CSF-induced macrophage differentiation in the presence, but not in the Indeed, anti-IL-l antibody abolished the collaborative effect of P-endorphin with LPS. Moreover, IL-l was effective even for C3HIHeJ mouse bone marrow cells. Naloxone, an antagonist of endorphins for opioid-receptors, completely abrogated the effect of P-endorphin. In a single-cell culture system, the collaboration between P-endorphin and IL-l was revealed by the increase in number and size of macrophage colonies, but collaboration between &endorphin and LPS did not occur. These results indicate that, in mixed cell culture, @-endorphin acts in concert with paracrinal IL-l induced by LPS to enhance M-CSF-dependent macrophage differentiation from immature precursor cells. absence, of LPS." The present experiment was conducted to determine whether P-endorphin serves as a regulator for M-CSF-induced macrophage differentiation. We show here that P-endorphin enhances the macrophage colony formation induced by M-CSF in the presence of LPS, and that the effect of LPS is attributed to the induction of IL-l production. In this way, &endorphin in concert with IL-I increases the responsiveness of immature progenitor cells to M-CSF.
MATERIALS AND METHODS
Mice. Female (BALBk X DBA/2)F, (C X D2 F,), C3H/HeN, and C3HIHeJ mice aged 6 to 1 1 weeks (Japan SLC Inc, Shizuoka, Japan) were used.
Agents and culture medium. Recombinant human M-CSF was a gift from Morinaga Milk Industry CO Ltd (Kanagawa, Japan) and Green Cross Research Laboratories (Osaka, Japan). LPS of Escherichia coli 01 1 ]:B4 was purchased from Difco Laboratories (Detroit, MI). RPMI I640 culture medium was prepared from a mixed powder (Nissui Seiyaku CO Ltd, Tokyo, Japan). Fetal calf serum (FCS) was obtained from Bioproducts Inc (Walkersville, MD). Endorphins (a.
p, and -y), methionine-enkephalin and naloxone were purchased from Peptide Institute, Inc (Osaka, Japan). Opioid peptides were dissolved in phosphate-buffered saline at a concentration of IO" m o I L aliquoted to plastic tubes, and stored at -90°C until use. They were diluted with the complete medium: RPMI 1640 medium supplemented with sodium bicarbonate, penicillin (100 U/mL), streptomycin (100 pg/mL), and 10% heat-inactivated FCS. Opioid peptides remaining in the tubes after each experiment were discarded. Recombinant human 1L-1 /3, used as a representative of 1L-I , was a gift from Otsuka Pharmaceutical CO Ltd (Tokushima, Japan). Recombinant human IL-6 was provided by Dr T. Hirano (Osaka University, Osaka, Japan). Recombinant human TNFa, rabbit anti-mouse IL-la. and rabbit antimouse IL-l@ were gifts from Dainippon Pharmaceutical CO Ltd (Osaka, Japan). These antisera were mixed for use to neutralize either type of IL-l, and the mixture is referred to as anti-[L-l in this report. Contaminating endotoxin in the culture medium was found to be very low (less than 10 pg/mL) as tested with a chromogenic endotoxin-specific assay (Endospacy; Seikagaku Kogyo CO Ltd. Tokyo, Japan).
Colony jiwmation. Femoral marrow cells were suspended in warm (42°C) RPMI 1640 medium containing 20% FCS, antibiotics and 0.3% agarose (Nakarai Chemicals CO Ltd, Kyoto, Japan) at a concentration of 3.0 X IO' nucleated cells per milliliter. The cell suspension ( I mL) was added to a 35-mm petri dish (Nunc 153006: A/S Nunc, Roskilde, Denmark) containing 0. Enrichment of murine bone marrow progenitor cells. Femoral marrow cells were incubated at 4°C for 30 minutes in a cocktail of predetermined optimal concentrations of antibodies to various differentiation antigens: RA3-3AU6.1 (anti-B220), N22 (anti-Ia), RB6-8C5 (anti-Gr-l), 3.155 (anti-CDg), and GK1.5 (anti-CD4).
Cells were washed twice and resuspended at a concentration of lo7/ mL in RPM1 medium containing a final 1/16 dilution of rabbit serum as complement. After 45 minutes incubation at 37"C, cells were washed twice and resuspended in the complete medium.
Single-cell proliferation assay. Bone marrow cells were seeded in Terasaki plates (Sumitomo Bakelite CO Ltd, Tokyo, Japan), one cell per well, in 10 pL of the complete medium supplemented with the noted cytokines. Wells were scored for cell proliferation 14 days later.
Statistical analyses. Each experiment was repeated at least three times with similar results. The results shown here are representative ones. All assays were performed in triplicate, and values given are the means 2 SD. Student's t test was used for determining significant differences between experimental and control groups; P .05 was considered to be statistically significant.
RESULTS
@Endorphin enhances macrophage colony formation in the presence of LPS. As described above, Moore et a124, 25 reported that the macrophage colony formation induced by M-CSF was enhanced by LPS, and that substance P amplified the enhancing effect of LPS. In this experiment, we investigated the effects of LPS at the same concentration as in their experiments and of graded concentrations of P- endorphin from mol/L to m o m on the M-CSFinduced colony formation of bone marrow macrophage progenitors in the presence or absence of LPS (Fig 1) . The number of colonies slightly increased when LPS was added. When P-endorphin was added to the culture together with LPS, the number of macrophage colonies increased in a dose-dependent manner and reached a plateau at a concentration of lo" m o a . Thus, we used P-endorphin at this concentration in the following experiments as the lowest concentration with maximum effect.
P-Endorphin and LPS have no collaborative augmenting effect on macrophage colony formation in LPS-unresponsive bone marrow cells. To confirm the requirement of LPS for the augmentation of colony formation by P-endorphin, we scored the number of macrophage colonies in bone marrow cells from LPS-responsive C3WHeN mice and LPS-unresponsive C3H/HeJ mice (Fig 2) . Enhancement of colony formation was detected only in the former, verifying that the augmenting effect of P-endorphin is dependent on LPSresponsive marrow cells.
a -and y-endorphins also enhance macrophage colony formation in the presence of LPS.
This experiment was conducted to investigate the effect of endorphins other than P-endorphin on colony formation in the presence of M-CSF plus LPS. As shown in Fig 3, a-endorphin and y-endorphin, which comprise the NH,-terminal 16 and 17 amino acid peptides of P-endorphin, respectively, also enhanced the formation of colonies in the presence of M-CSF plus LPS. Methionine-enkephalin, which is the NH2-terminal pentapeptide of P-endorphin, was also effective (data not shown). These results suggest that the NH2-terminal portion of P- endorphin plays an important role in enhancing colony formation.
Effect of LPS is mediated by IL-I. LPS is a potent agent in the induction of cytokines such as IL-I, TNF, and IL-6, which are known to enhance myelopoiesis in vitro.'"*' Therefore, we examined the effect of these cytokines on M-CSF-dependent macrophage colony formation in the presence or absence of 0-endorphin. As shown in Table 1 , only IL-l was effective in collaborating with P-endorphin to enhance macrophage colony formation, although both IL-1 and TNF augmented M-CSF-induced macrophage differentiation. IL-6 showed no augmenting effect, and even had an inhibitory effect, in both the presence and absence of pendorphin. Thus, IL-I seemed to be a primary mediator of the effect of LPS on colony formation. To confirm this possibility, we added anti-IL-l antibody to the bone marrow cell culture stimulated with the combination of M-CSF, LPS, and P-endorphin (Fig 4) . Anti-IL-l antibody abrogated the LPS-dependent enhancing effect of &endorphin. The idea that IL-l is a primary mediator of the effect of LPS was consistent also with the experimental result shown in Fig 5: &endorphin augmented colony formation from LPS-unresponsive (C3HMeJ) bone marrow cells as well as from C3HFIeN cells in the presence of IL-I.
Efect of &endorphin is mediated through classical opioid receptors. We attempted to determine whether P-endorphin indeed functioned through classical opioid receptors. Naloxone, an antagonist of endorphins for classical opioid receptors, at a concentration of IO-' mol/L abolished the effect of P-endorphin but had no effect on the colony formation enhanced by IL-l (Fig 6) .
These results strongly suggest that M-CSF-dependent macrophage differentiation can somehow be regulated by signals via classical opioid receptors.
Dose response of IL-I with or without @endorphin. The efficicacy of &endorphin at varying concentrations of IL-I was investigated (Fig 7) . Marked enhancement of colony formation by P-endorphin was observed at concentrations of IL-I as low as 0.03 U/mL and 0.3 U/mL, but no effect of IL-I at the same concentrations was observed in the absence of P-endorphin. The number of macrophage colonies formed in the presence of &endorphin increased with the dose of IL- 1 Table 2 , IL-l by itself was capable of increasing both the Table 2 
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Bone marrow cells from CxD2 F, mice were depleted of cells with various lineage-specific markers and cultured with 1,000 U/mL M-CSF in the presence or absence of LPS (100 pgbnL), IL-18 (1 U/mL), and 8-endorphin (IO" mol/L) in Terasaki microtiter plates at a concentration of one cell per well. Wells were scored for cell growth after 14 days of incubation. Scoring criteria: 1, 1 to 50 cells per well; 2, less than 10% of well area was covered by cells; 3, 10% to 25% of well area covered by cells; 4, 25% to 50% of well area covered by cells; 5, more than 50% of well area covered by cells.
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From number of responding progenitors and the size of colonies, but IL-l plus P-endorphin increased the number and size of macrophage colonies even more. However, neither the number nor the size of macrophage colonies was affected by pendorphin without IL-l. We consider that @-endorphin in combination with IL-l facilitates the differentiation of precursor cells to acquire the responsiveness to M-CSF. Table 2 also shows that LPS alone or LPS plus @-endorphin neither increased the number of macrophage colonies nor affected the cell growth induced by M-CSF. This suggests that the effect of LPS observed in bulk cell culture (eg, Fig 1) is mediated by the paracrinal action of IL-l secreted from some LPS-stimulated cells on macrophage progenitor cells.
DISCUSSION
The present study demonstrates that P-endorphin is able to enhance M-CSF-induced bone marrow cell differentiation to macrophages under in vitro conditions. The effect of P-endorphin becomes evident when the bulk population of bone marrow cells is cultured with M-CSF plus either LPS Table   1 ). LPS is needed primarily to induce the production of IL-1 (Figs 4 and 5, and Table l), and the cooperative effect of IL-1 and P-endorphin can be attributed to the enhancement of the responsiveness of macrophage precursor cells to M-CSF ( Table 2) .
The experiment with naloxone indicates that P-endorphin indeed functions via classical opioid receptors (Fig 6) . This is consistent with the results that a-endorphin, y-endorphin, and methionine-enkephalin, all of which can bind only with classical opioid r e c e p t o r~, 7~,~~ also enhance the response (Fig  3 and data not shown) . Lolait et a12*' have reported that spleen macrophages express mRNA for proopiomelanocortin, the precursor molecule of P-endorphin, and secrete endorphinlike immunoreactive substance. Other investigators have also demonstrated that murine T helper cells and human peripheral blood mononuclear cells synthesize molecules that react with antimethionine-enkephalin and anti-@-endorphin antibodies, re~pectively.4~~ Considering these observations, our results suggest that endogenous opioid peptides may be generated by bone marrow cells, and their binding to specific receptors may play a pivotal role in the process of hematopoiesis.
LPS is a potent stimulator of the production of cytokines such as IL-1, TNF, and IL-6 in various cell type~.'~-~' These cytokines are known to enhance hematopoiesis in the bone m a r r o~. '~-~~ In this study, IL-1 was found to be involved in the enhancement of M-CSF-dependent macrophage differentiation by &endorphin (Figs 4 and 5 and Table 1 ). Although some cytokines other than IL-l may be produced by LPS-stimulated bone marrow cells, neither TNFa nor IL-6 was found to potentiate the response in collaboration with P-endorphin ( Table 1) .
Opioid peptides have been reported to regulate cytokine production in murine macrophages, natural killer cells, and CD4+ T cells.'1.12~'6 Therefore, it is possible that the collaborative effect of P-endorphin with LPS is due to the augmentation of IL-1 production induced by LPS. In the absence of P-endorphin, 0.0277 UlmL IL-1 was detected in the culture supernatant of bone marrow cells stimulated with M-CSF plus LPS. The addition of P-endorphin caused a slight but significant increase in IL-1 activity (0.0464 U/mL; P < .OS).
However, in the range of these IL-l concentrations, IL-I exerted no effect on the colony formation unless P-endorphin was present (Fig 7) . On the other hand, IL-1 by itself at high doses is able to enhance the macrophage colony formation induced by M-CSF. Therefore, these results seem to indicate that the major effect of P-endorphin on macrophage colony formation is due to amplification of the effect of IL-1.
The cells that produce IL-1 after LPS stimulation were not identified in this study. We surmise, however, that bone marrow macrophages and/or stroma type cells are responsible, as the removal of adherent cells from the bone marrow cell preparation resulted in a reduction of the enhancing effect of LPS (data not shown). In contrast with the semisolid culture of bulk bone marrow cells, the addition of LPS plus @-endorphin to the single-cell culture with M-CSF did not increase the frequency of the occurrence of macrophage colonies per unit number of cells (Table 2 ). This suggests that IL-I, which is possibly produced during culture by the M-CSF-reactive growing cells stimulated by LPS, does not affect proliferation by its autocrinal action. We conclude that the augmenting activity of IL-I produced in bone marrow cell cultures is due to its paracrinal action on immature progenitor cells.
In accord with some other investigators,'"'' we found that IL-l enhances both the number and size of M-CSF-induced macrophage colonies ( Table 2) , showing that it acts on immature precursor cells to induce or augment responsiveness to M-CSF. @-endorphin had no autonomous effect on macrophage progenitors, but it amplified the effect of IL-I in the single-cell assay system. Therefore, immature progenitors that have yet to acquire responsiveness to M-CSF are most probably targets for the cooperative effect of @-endorphin and IL-1. It is feasible that @-endorphin promotes the differentiation of IL-1 -reactive precursor cells, which then acquire responsiveness to M-CSF. It is also possible that @-endorphin enhances the reactivity of immature progenitors to IL-1. If this is the case, P-endorphin could further augment the colony formation induced by high doses of IL-l in the experiment shown in Fig 7. However, the number of colonies formed in the presence of @-endorphin and IL-l reached a plateau at the level induced by a high dose of IL-I alone. Thus, this possibility does not seem to be likely.
We and other investigators have documented that @-endorphin affects macrophage functions, such as the production of superoxide and the expression of tumoricidal a~tivity.".'~.'' The study presented here focused on the effect of &endor-phin on macrophage differentiation and provided evidence of its cooperative effect with IL-l, possibly produced by bone marrow macrophages and/or stromal cells. The regulation of hematopoiesis by opioid peptides is an intriguing subject in the investigation of the mechanisms of the phenomena related to stress.
